Brought to you by:
Outgoing SVS president’s message of unity: ‘We must work together to improve, advance vascular care’
The Society for Vascular Surgery (SVS) is no longer the organization it was half a century ago. That was one of the core messages from the Society’s now Immediate Past President Ali AbuRahma, MD, during his Presidential Address at the…
Jonathan Towne honored with SVS Lifetime Achievement Award
An “amazing clinician and leader.” Devoted to the specialty of vascular surgery. Investigator and researcher. Champion of the in-situ technique for lower-extremity bypass. Former SVS secretary and president. And a leader in creating the Vascular Surgery Board (VSB). For all…
Terumo Aortic announces first commercial implant of Thoraflex Hybrid in US
Following the recent approval by the Food and Drug Administration (FDA) of the Thoraflex Hybrid frozen elephant trunk (FET) device for the treatment of patients with complex aortic arch disease, Terumo Aortic has now announced the first commercial implant of…
Cydar Medical and King’s College London partner on randomized controlled trial of Cydar EV Maps
Cydar Medical has partnered with King’s College London to initiate the ARIA study—a randomized controlled trial to assess the clinical-, technical- and cost-effectiveness of a cloud-based, artificially intelligent image fusion system in comparison to standard treatment to guide endovascular aortic…
SVS creates limb salvage-focused Frank J. Veith Lectureship
Next year’s Vascular Annual Meeting (VAM) will include a new named lecture: the Frank J. Veith Lecture, named in honor of former Society for Vascular Surgery (SVS) President Frank Veith, MD. Immediate Past President Ali AbuRahma, MD, announced the new…
Vascular surgery review book seeks to plug hole in VSITE preparation process
When University of Massachusetts Medical School integrated vascular surgery resident Thomas Creeden, DO, was preparing for his first Vascular Surgery In-Training Exam (VSITE), it struck him there was a gap in the market. While those training in most other surgical…
Bolstering the workforce: Session details how to start a vascular training program
The workforce shortage issues set to plague vascular surgery over the next few decades, alongside an aging population and increase in vascular disease, formed the backdrop to a 2022 Vascular Annual Meeting (VAM) breakout session in Boston (June 15–18) designed…
Off-the-shelf branched endograft for TAAAs demonstrates safety and effectiveness through two years in both stable, symptomatic patients
Two-year target vessel-related freedom from all-cause and aneurysm-related mortality for an off-the-shelf multibranched endovascular device for the treatment of thoracoabdominal aortic aneurysms (TAAAs) came in at 78.5% and 98.6%, 2022 Vascular Annual Meeting (VAM) attendees heard. The data relate to…
New SVS president outlines priorities for his tenure as Society aims to reach out
Michael Dalsing, MD, who took over as Society for Vascular Surgery (SVS) president at the 2022 Vascular Annual Meeting (VAM) in Boston (June 15–18), talks about the priorities he has set out for his time at the helm, which include…
New project will develop nanoparticles with imaging and medicine-delivery capabilities to better treat PAD
A University of Texas at Arlington bioengineer is leading a project to develop biodegradable nanomaterials that will take pictures and deliver medicine to combat peripheral arterial disease (PAD), the university announced in a press release. Kytai Nguyen, a UTA bioengineering…